FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006868022> ?p ?o ?g. }

• W2006868022 endingPage "114" @default.
• W2006868022 startingPage "102" @default.
• W2006868022 abstract "On the basis of the recently reported observation that gonadotropin-releasing hormone agonists (GnRH-a) can affect endometrial cell proliferation, both indirectly, through the hormonal axis, and directly, by acting on the GnRH-a receptors, we investigated how far GnRH-a can be used as a new treatment mode for endometrial hyperplasias. Forty-two women, aged 28-60 years, with histologically confirmed simple (n = 30) or complex (n = 12, 2 with atypias) hyperplasia of the endometrium were involved in the study. According to the protocol they were treated for 6 months with GnRH-a (leuprolide acetate or triptorelin), and each patient underwent uterine curettage in the third and the sixth month of treatment, and 6 and at least 12 months after cessation of the treatment, for histological examination and morphometric and DNA-cytometric evaluation of the endometrium (mean pathological follow-up, 19.2 months; mean clinical follow-up, 30.7 months). During treatment, most of the women first revealed endometrial atrophy, and, after cessation of the treatment, again an atrophic or mainly functional endometrium; in 7 women, all with initial diagnosis of simple hyperplasia, the endometrial hyperplasia reappeared, which led in all 7 cases to hysterectomy. The mean values of almost all morphometric and DNA-cytometric parameters during and after treatment showed statistically significant changes in relation to pretreatment values, indicating a decrease in the proliferative activity of the endometrial cells; the GnRH-a antiproliferative effect was still active for a long time after cessation of the therapy. Our results, based for the first time not only on histological but also on serial nuclear morphometric and DNA-cytometric examinations of the endometrial cells and on the longest follow-up time, support the view that in cases of endometrial hyperplasia, especially of complex type, the use of GnRH agonists, which decrease the proliferative tendency of endometrial cells, could represent an alternative conservative therapeutic approach, which, however, requires close monitoring of the endometrium." @default.
• W2006868022 created "2016-06-24" @default.
• W2006868022 creator A5005104442 @default.
• W2006868022 creator A5011093089 @default.
• W2006868022 creator A5025496795 @default.
• W2006868022 creator A5071642148 @default.
• W2006868022 creator A5081007156 @default.
• W2006868022 date "1997-04-01" @default.
• W2006868022 modified "2023-10-05" @default.
• W2006868022 title "Treatment of Endometrial Hyperplasias with Gonadotropin-Releasing Hormone Agonists: Pathological, Clinical, Morphometric, and DNA-Cytometric Data" @default.
• W2006868022 cites W178850739 @default.
• W2006868022 cites W1991534174 @default.
• W2006868022 cites W1991538165 @default.
• W2006868022 cites W2000410484 @default.
• W2006868022 cites W2006112738 @default.
• W2006868022 cites W2007838802 @default.
• W2006868022 cites W2021488191 @default.
• W2006868022 cites W2027053986 @default.
• W2006868022 cites W2033040258 @default.
• W2006868022 cites W2041131741 @default.
• W2006868022 cites W2049941029 @default.
• W2006868022 cites W2059898790 @default.
• W2006868022 cites W2068985735 @default.
• W2006868022 cites W2076278734 @default.
• W2006868022 cites W2081867227 @default.
• W2006868022 cites W2097113048 @default.
• W2006868022 cites W2140154010 @default.
• W2006868022 cites W2292879214 @default.
• W2006868022 cites W2412811517 @default.
• W2006868022 cites W4318444802 @default.
• W2006868022 cites W56557460 @default.
• W2006868022 doi "https://doi.org/10.1006/gyno.1997.4639" @default.
• W2006868022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9103399" @default.
• W2006868022 hasPublicationYear "1997" @default.
• W2006868022 type Work @default.
• W2006868022 sameAs 2006868022 @default.
• W2006868022 citedByCount "34" @default.
• W2006868022 countsByYear W20068680222012 @default.
• W2006868022 countsByYear W20068680222015 @default.
• W2006868022 countsByYear W20068680222016 @default.
• W2006868022 countsByYear W20068680222017 @default.
• W2006868022 countsByYear W20068680222020 @default.
• W2006868022 countsByYear W20068680222021 @default.
• W2006868022 countsByYear W20068680222022 @default.
• W2006868022 crossrefType "journal-article" @default.
• W2006868022 hasAuthorship W2006868022A5005104442 @default.
• W2006868022 hasAuthorship W2006868022A5011093089 @default.
• W2006868022 hasAuthorship W2006868022A5025496795 @default.
• W2006868022 hasAuthorship W2006868022A5071642148 @default.
• W2006868022 hasAuthorship W2006868022A5081007156 @default.
• W2006868022 hasConcept C126322002 @default.
• W2006868022 hasConcept C126894567 @default.
• W2006868022 hasConcept C134018914 @default.
• W2006868022 hasConcept C142724271 @default.
• W2006868022 hasConcept C207886595 @default.
• W2006868022 hasConcept C2777562237 @default.
• W2006868022 hasConcept C2777689261 @default.
• W2006868022 hasConcept C2778575703 @default.
• W2006868022 hasConcept C2778782382 @default.
• W2006868022 hasConcept C2778894405 @default.
• W2006868022 hasConcept C2779448150 @default.
• W2006868022 hasConcept C2779494336 @default.
• W2006868022 hasConcept C2779742232 @default.
• W2006868022 hasConcept C2779904257 @default.
• W2006868022 hasConcept C2781172350 @default.
• W2006868022 hasConcept C29456083 @default.
• W2006868022 hasConcept C71315377 @default.
• W2006868022 hasConcept C71924100 @default.
• W2006868022 hasConceptScore W2006868022C126322002 @default.
• W2006868022 hasConceptScore W2006868022C126894567 @default.
• W2006868022 hasConceptScore W2006868022C134018914 @default.
• W2006868022 hasConceptScore W2006868022C142724271 @default.
• W2006868022 hasConceptScore W2006868022C207886595 @default.
• W2006868022 hasConceptScore W2006868022C2777562237 @default.
• W2006868022 hasConceptScore W2006868022C2777689261 @default.
• W2006868022 hasConceptScore W2006868022C2778575703 @default.
• W2006868022 hasConceptScore W2006868022C2778782382 @default.
• W2006868022 hasConceptScore W2006868022C2778894405 @default.
• W2006868022 hasConceptScore W2006868022C2779448150 @default.
• W2006868022 hasConceptScore W2006868022C2779494336 @default.
• W2006868022 hasConceptScore W2006868022C2779742232 @default.
• W2006868022 hasConceptScore W2006868022C2779904257 @default.
• W2006868022 hasConceptScore W2006868022C2781172350 @default.
• W2006868022 hasConceptScore W2006868022C29456083 @default.
• W2006868022 hasConceptScore W2006868022C71315377 @default.
• W2006868022 hasConceptScore W2006868022C71924100 @default.
• W2006868022 hasFunder F4320308269 @default.
• W2006868022 hasFunder F4320320882 @default.
• W2006868022 hasFunder F4320323846 @default.
• W2006868022 hasIssue "1" @default.
• W2006868022 hasLocation W20068680221 @default.
• W2006868022 hasLocation W20068680222 @default.
• W2006868022 hasOpenAccess W2006868022 @default.
• W2006868022 hasPrimaryLocation W20068680221 @default.
• W2006868022 hasRelatedWork W2004275026 @default.
• W2006868022 hasRelatedWork W2006868022 @default.
• W2006868022 hasRelatedWork W2046225717 @default.
• W2006868022 hasRelatedWork W2065038274 @default.

• next